Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Molecular Biology of Cancer -

The Molecular Biology of Cancer

Buch | Softcover
544 Seiten
2006
Wiley-Blackwell (an imprint of John Wiley & Sons Ltd) (Verlag)
978-1-4051-1814-9 (ISBN)
CHF 94,35 inkl. MwSt
zur Neuauflage
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
This comprehensive text provides a detailed overview of the molecular mechanisms underpinning the development of cancer and its treatment. Written by an international panel of researchers, specialists and practitioners in the field, the text discusses all aspects of cancer biology from the causes, development and diagnosis through to the treatment of cancer. * Written by an international panel of researchers, specialists and practitioners in the field * Covers both traditional areas of study and areas of controversy and emerging importance, highlighting future directions for research * Features up-to-date coverage of recent studies and discoveries, as well as a solid grounding in the key concepts in the field * Each chapter includes key points, chapter summaries, text boxes, and topical references for added comprehension and review * Supported by a dedicated website at www.blackwellpublishing.com/pelengaris * An excellent text for upper-level courses in the biology of cancer, for medical students and qualified practitioners preparing for higher exams, and for researchers and teachers in the field

Stella Pelengaris PhD is a Senior Research Fellow in Molecular Medicine in the Department of Biological Sciences at the University of Warwick and Warwick Medical School. While working as a PDRA at the Imperial Cancer Research Fund, she established a series of unique model systems for studying the role of c-Myc and apoptosis in cancer initiation and reversal. Since 1999 she and Mike Khan have jointly run the cancer biology research group at the University of Warwick where, in collaboration with Gerard Evan, they have confirmed the inherent tumor-suppressor activity of c-Myc (apoptosis) as a major barrier to oncogenic deregulation of c-Myc. The group is currently researching the role of c-Myc in both oncogenesis and in the apoptosis of beta cells in diabetes. Mike Khan PhD FRCP is a Consultant Endocrinologist and Physician at the University Hospitals of Coventry and Warwickshire and Head of Molecular Medicine at the University of Warwick and Warwick Medical School. He was elected as a Fellow of the Royal College of Physicians in 2002 and as a Member of the Association of Physicians in 2004. His main research interests have been in the regulation of tissue growth and plasticity during development and in adult tissue homeostasis. Currently, he is collaborating with mathematicians and others in a systems biology approach to define key functional gene and protein networks involved in regulating cell fate. Dr Khan and Dr Pelengaris jointly run various postgraduate training courses at masters level and beyond in cancer biology and in lipid metabolism/diabetes. They also are coauthors of the textbook Lipids and Diabetes (2002).

Preface. 1. Introduction: Stella Pelengaris & Mike Khan (both University of Warwick). 2. The Burden of Cancer: Will Steward & Anne Thomas (both University of Leicester). 3. Nature and Nurture in Oncogenesis: Stella Pelengaris & Mike Khan (both University of Warwick). 4. DNA Replication and the Cell Cycle: Stella Pelengaris & Mike Khan (both University of Warwick). 5. Regulation of Growth: Growth Factors, Receptors and Signaling Pathways: Stella Pelengaris & Mike Khan (both University of Warwick). 6. Oncogenes: Stella Pelengaris & Mike Khan (both University of Warwick). 7. Tumor Suppressor Genes: Martine Roussel (St. Jude's Children's Cancer Research Hospital). 8. Apoptosis: Stella Pelengaris & Mike Khan (both University of Warwick). 9. Telomeres and Senescence: Maria Blasco & Mike Khan (Spanish National Cancer Center, Madrid; University of Warwick). 10. Genetic Instability, Chromosomes, and Repair: Stella Pelengaris & Mike Khan (both University of Warwick). 11. Cancer is More Than a Genetic Condition: Stella Pelengaris & Mike Khan (both University of Warwick). 12. Cell-Matrix Adhesion, Cell-Cell Interactions and Malignancy: Charles Streuli (University of Manchester). 13. Tumor Immunity and Immunotherapy: Cassian Yee (Fred Hutchinson Cancer Research Center, University of Washington). 14. Angiogenesis: David T. Shima & Christiana Ruhrberg (Eyetech Research Center; University College of London). 15. Diagnosis of Cancer: Anne Thomas & Will Steward (both University of Leicester). 16. Treatment of Cancer: Chemotherapy and Radiotherapy: Anne Thomas (University of Leicester), R. A. Sharma (Royal Marsden Hospital, UK) and Will Steward (University of Leicester). 17. Caring For the Cancer Patient: Nicky Rudd & Esther Waterhouse (Both University Hospitals of Leicester and LOROS Hospice). 18. Genomics and Proteomics in Cancer Research and Diagnosis: Norbert C.J. de Wit (University of Warwick). Glossary. Index

Erscheint lt. Verlag 27.3.2006
Zusatzinfo 206
Verlagsort Chicester
Sprache englisch
Maße 190 x 245 mm
Gewicht 1308 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Humangenetik
ISBN-10 1-4051-1814-8 / 1405118148
ISBN-13 978-1-4051-1814-9 / 9781405118149
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
CHF 22,40